Trend Results : Pfizer Animal Health


Blog Post Results (1-20 of 71)

FILTER RESULTS

Zoetis, an Animal Health Company, Says Ackman Has Taken a Stake

The company, the former animal health arm of Pfizer, said in a statement that it had received a call from William A. Ackman about the investment by his activist hedge fund.

Pfizer Inc. (PFE), Zoetis Inc (ZTS), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): 5 Reasons to Invest in Animal Health

In an attempt to further simplify its business and unlock shareholder value, Pfizer Inc. (NYSE:PFE) has been busy divesting itself of non-core assets. Last year, that involved the sale of its infant nutrition business to Nestle. And earlier this year, that simplification process led to Pfizer spinning off its animal health care division into a separate […]

Cryoport/Zoetis expand poultry vaccine logistic deal

Cryoport has reached agreement with Zoetis, the former animal health business unit of Pfizer, to expand the scope of the cold chain logistics services Cryoport is providing.

Zoetis and BPC sponsor Poultry Trainee of Year Award

Entries are invited for the Zoetis/BPC Poultry Trainee of the Year Award – sponsored by Zoetis, formerly the animal health business unit of Pfizer Inc., and the British Poultry Council is now fully involved for the first time.

Zoetis marks separation from Pfizer

Zoetis, the former animal health business of Pfizer has marked its separation from Pfizer and first day as a fully independent company.

Pfizer Updates Guidance After Investors Take Zoetis Off Its Hands

When spun out in a February IPO it still held a sizable stake in the animal health business, but now after an oversubscribed exchange offer the drugmaker has completed its exit. The offer allowed shareholders to exchange some, all or none of their shares for at a conversion rate of 0.9898 shares of the latter [...]

Zoetis™ Declares Third-Quarter 2013 Dividend

Zoetis™ Declares Third-Quarter 2013 Dividend FLORHAM PARK, N.J.--(BUSINESS WIRE)-- The Board of Directors of Zoetis Inc. ( NYS: ZTS ), formerly the animal health business of Pfizer Inc., has declared a third-quarter dividend payable to holders of the company's common stock of $0.065 per share. Show More Summary

Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN): Is Concentration Better Than Diversification in Pharma?

Pfizer Inc. (NYSE:PFE) recently completed the spin-off of its animal health unit, Zoetis Inc (NYSE:ZTS). The company offered to acquire its stake in Zoetis for a 7% discount, in exchange of all or part of its shareholding. This is subject to an upper limit of 0.9898 shares of Zoetis common stock per share of Pfizer [...]

Pfizer Inc. (PFE), Zoetis Inc (ZTS): 4 Investment Opportunities in Animal Health

Pfizer Inc. (NYSE:PFE) recently announced plans to sell its remaining 80% stake in animal-health company Zoetis Inc (NYSE:ZTS) after about four months on the public market. Margins and profits aren’t as high in the animal health business, which has pushed the world’s largest pharmaceutical company to streamline its focus. It also highlights a delicate Catch-22 for [...]

Should You Trade Pfizer Inc. (PFE) Stock for Shares in Zoetis Inc (ZTS)?

Owners of Pfizer Inc. (NYSE:PFE) stock have an animal of a decision to make. The pharma giant is giving shareholders a chance to exchange Pfizer stock for shares in Zoetis Inc (NYSE:ZTS), its former animal health business that was spun out in February. Pfizer Inc. (NYSE:PFE) still owns 80% of Zoetis but is willing to give [...]

Should You Trade Pfizer Stock for Shares in Zoetis?

Owners of Pfizer stock have an animal of a decision to make. The pharma giant is giving shareholders a chance to exchange Pfizer stock for shares in Zoetis, its former animal health business that was spun out in February. Pfizer still...Show More Summary

4 Investment Opportunities in Animal Health

Pfizer recently announced plans to sell its remaining 80% stake in animal-health company Zoetis after about four months on the public market. Margins and profits aren't as high in the animal health business, which has pushed the world's largest pharmaceutical company to streamline its focus. Show More Summary

Invest in Your Pets for Less

Pfizer is busy downsizing from health-care conglomerate to a focused pharmaceutical company. It sold off its nutrition business to Nestle for $12 billion and spun out 20% of its animal health division into a new company, Zoetis, forShow More Summary

Theravance Inc (THRX), Elan Corporation, plc (ADR) (ELN), GlaxoSmithKline plc (ADR) (GSK): Biotech Companies Breaking Up

If pharmaceutical companies can break up, why not biotech companies? Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into animal health products into Zoetis, Theravance Inc (NASDAQ:THRX) is splitting up. Show More Summary

Biotech Companies Breaking Up

If pharmaceutical companies can break up, why not biotech companies? Following in the footsteps of Abbott spinning out its drug division into AbbVie, and Pfizer spinning out its animal health division into animal health products into...Show More Summary

Zoetis™ Declares Second-Quarter 2013 Dividend

Zoetis™ Declares Second-Quarter 2013 Dividend MADISON, N.J.--(BUSINESS WIRE)-- The Board of Directors of Zoetis TM ( NYS: ZTS ), formerly the animal health business of Pfizer Inc., has declared a second-quarter dividend payable to holders of the company's Class A common stock and Class B common stock of $0.065 per share. Show More Summary

Zoetis™ to Host Webcast and Conference Call on First-Quarter 2013 Financial Results

Zoetis™ to Host Webcast and Conference Call on First-Quarter 2013 Financial Results MADISON, N.J.--(BUSINESS WIRE)-- Zoetis TM ( NYS: ZTS ), formerly the animal health business of Pfizer Inc., will host a webcast and conference call at 8:30 a.m. Show More Summary

Zoetis unveils its vision for EuAfME

Zoetis, formerly the animal health business unit of Pfizer, announced its vision for business in Europe, Africa and the Middle East (EuAfME). Building on 60 years of experience in the animal health sector, the company aims to have its products, services and people as the most valued by animal health customers around the region, and the world.

Is Merck Changing Its Strategy?

There has been a flurry of activity in the pharmaceutical industry lately: Pfizer spun-out it's animal health division into Zoetis, Abbott spun-out it's branded drug-making unit into AbbVie, and AstraZeneca recently changed its chief executive. Show More Summary

Zoetis Inc (ZTS): A Global Leader in Animal Health – Spinoff Opportunity?

Although spin-off situations offered investors compelling investment opportunities most of the time, investors should study each situation quite carefully to determine its own attractiveness. Recently, Pfizer Inc. (NYSE:PFE) has sold 86.1 million class A shares in its animal health unit, Zoetis Inc (NYSE:ZTS) in the form of an IPO. Show More Summary

Copyright © 2015 Regator, LLC